AF
ANIP icon

Allworth Financial’s ANI Pharmaceuticals ANIP Stock Holding History

Allworth Financial’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.4K Buy
29
+27
+1,350% +$2.17K ﹤0.01% 4434
2026
Q1 		$154 Hold
2
– – ﹤0.01% 4954
2025
Q4 		$158 Sell
2
-18
-90% -$1.56K ﹤0.01% 4728
2025
Q3 		$1.83K Sell
20
-2
-9% -$163 ﹤0.01% 4044
2025
Q2 		$1.44K Buy
+22
New +$1.43K ﹤0.01% 3842

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allworth Financial's ANIP Position: Q2 2026 in Review

Allworth Financial increased its ANI Pharmaceuticals (ANIP) stake by 1,350% in Q2 2026, buying an estimated $2.17K and bringing the position to 29 shares worth $2.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4434.

Allworth Financial first reported a position in ANIP in Q2 2025 and has held it in 5 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Allworth Financial held 29 shares of ANI Pharmaceuticals worth $2.4K as of Q2 2026.
  • Allworth Financial bought 27 ANI Pharmaceuticals shares in Q2 2026, an estimated $2.17K.
  • ANI Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4434 holding.
  • Allworth Financial first reported a position in ANI Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.